Compositions and methods for the treatment of inflammation and pain
US-10343994-B2 · Jul 9, 2019 · US
US11014885B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11014885-B2 |
| Application number | US-201816618896-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 5, 2018 |
| Priority date | Jun 5, 2017 |
| Publication date | May 25, 2021 |
| Grant date | May 25, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Disclosed is a new method for preparing a donepezil pamoate (1-benzyl-4-[(5,6-dimethoxyindan-2-one)methyl]piperidine pamoate). The donepezil pamoate prepared by using the method has a high purity and a good flowability.
Opening claim text (preview).
The invention claimed is: 1. A method for preparing a crystal form A of a compound of formula I, comprising dissolving the compound of formula I in a reaction solvent and adding another solvent dropwise for precipitation to give the crystal form A of the compound of formula I, wherein the reaction solvent is acetone, and wherein another solvent is water. 2. The method according to claim 1 , wherein dissolving is carried out at a temperature of from 0 to 50° C. 3. The method according to claim 1 , wherein dissolving is carried out at a temperature of from 15 to 30° C. 4. The method according to claim 1 , wherein adding another solvent dropwise is carried out at a temperature of 0 to 50° C. 5. The method according to claim 1 , wherein adding another solvent dropwise is carried out at a temperature of 15 to 30° C.
with carboxyl groups on a condensed ring system containing two rings · CPC title
Crystalline forms, e.g. polymorphs · CPC title
for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia · CPC title
by change of the physical state, e.g. crystallisation · CPC title
by oxygen atoms · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.